Lanean...
(131)I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma
Radioimmunotherapy (RIT) options for T-cell non-Hodgkin lymphomas (T-NHLs) are limited. We evaluated anti-CD45-RIT in human (h) and murine (m) T-NHL. CD45 was highly expressed on hT-NHL patient samples (median, 2.3 × 10(5) antigen-binding capacity units/cell) and hT-NHL cell lines (3.4 × 10(5) CD45...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2700326/ https://ncbi.nlm.nih.gov/pubmed/19332764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-205476 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|